About James Schmidt
James Schmidt is a chief financial officer at Alume Biosciences.
James Schmidt reports to the SEC as an officer of 1 public company: Receptos (RCPT).
James Schmidt first appears on SEC filings in 2013.
Experience
This experience comes from James Schmidt's profile and from SEC filings. For roles taken from filings, the years are when the filings name James Schmidt in the role, so the role may have started earlier or lasted longer.
Alume Biosciences Inc Current
Chief Financial Officer
2018 – Present · LA Jolla, CA
Develops drugs to help surgeons see nerves during operations.
AI
Abilita Bio, Inc. Current
Chief Financial Officer
2014 – Present
EP
Escient Pharmaceuticals
Vice President, Finance and Administration
2020 – 2024
RI
Receptos, Inc.
VP Finance & Administration
Vice President Finance & Administration (2008 – 2013)
2008 – 2013 · Public company (RCPT)
CT
Conforma Therapeutics
Senior Director Finance & Operations
2001 – 2006
Key Colleagues at Startups
The people James Schmidt works with at each company, as listed on that company's latest Form D.
Alume Biosciences Inc · Form D/A, May 8, 2026
Kim Kamdar
Board Member
Jean-Pierre Millon
Board Member
Kaveri Parker
Chief Business Officer
Brett Berman
Chief Medical Officer and director
Dan Bradbury
Executive Chair
Quyen Nguyen
Chief Executive Officer and director
Magda Marquet
Board Member